INSP - CIK 0001609550
The table below shows Inspire Medical Systems, Inc.'s cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating cash flow | $116.98M | $130.25M | $24.65M | $11.57M | -$20.12M | -$53.05M |
| Capital expenditure | $38.50M | $39.12M | $23.63M | $9.10M | $4.67M | $2.46M |
| Investing cash flow | $21.45M | -$113.12M | -$294.82M | -$19.60M | $29.14M | $86.63M |
| Dividends paid | - | - | - | - | - | - |
Inspire Medical Systems, Inc. reported operating cash flow of $116.98M for fiscal year 2025. That is down 10.2% from $130.25M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow grew from -$17.95M (FY 2016) to $116.98M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Stock buybacks | $175.02M | $0.00 | $0.00 | $0.00 | - | - |
| Financing cash flow | -$183.45M | -$52.39M | $13.95M | $235.08M | $14.95M | $134.06M |